Tibet AIM Pharm. Inc. (SHE:002826)
China flag China · Delayed Price · Currency is CNY
21.47
+1.20 (5.92%)
Feb 27, 2026, 3:04 PM CST

Tibet AIM Pharm. Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
4,0211,9012,2631,9432,0941,872
Market Cap Growth
100.50%-16.02%16.48%-7.19%11.85%-4.18%
Enterprise Value
3,4701,5271,9811,6951,9541,760
Last Close Price
21.4710.3211.7810.0210.669.42
PE Ratio
45.1341.39147.1044.0349.2945.55
PS Ratio
6.402.923.392.272.893.11
PB Ratio
5.012.553.022.592.912.72
P/TBV Ratio
5.252.713.222.873.252.93
P/FCF Ratio
28.9219.1413.8329.7824.8329.57
P/OCF Ratio
27.2917.0413.5628.3919.1118.40
EV/Sales Ratio
5.532.342.971.982.692.92
EV/EBITDA Ratio
40.7731.2840.3924.5629.9531.46
EV/EBIT Ratio
52.9856.0179.5336.6046.9944.89
EV/FCF Ratio
24.9615.3712.1025.9823.1727.80
Debt / Equity Ratio
0.030.030.020.07-0.06
Debt / EBITDA Ratio
0.310.470.220.73-0.71
Debt / FCF Ratio
0.190.230.070.77-0.63
Net Debt / Equity Ratio
-0.69-0.54-0.50-0.36-0.25-0.24
Net Debt / EBITDA Ratio
-6.47-8.29-7.64-3.93-2.80-2.95
Net Debt / FCF Ratio
-3.96-4.07-2.29-4.16-2.17-2.61
Asset Turnover
0.620.700.690.930.840.69
Inventory Turnover
3.164.116.2312.1517.1215.35
Quick Ratio
2.492.762.512.003.221.94
Current Ratio
2.673.012.862.193.652.06
Return on Equity (ROE)
11.24%6.35%2.10%6.27%6.18%6.14%
Return on Assets (ROA)
4.07%1.84%1.60%3.14%3.00%2.81%
Return on Invested Capital (ROIC)
18.39%5.99%3.89%7.07%6.82%6.46%
Return on Capital Employed (ROCE)
8.10%3.60%3.30%6.10%5.70%5.70%
Earnings Yield
2.14%2.42%0.68%2.27%2.03%2.20%
FCF Yield
3.46%5.23%7.23%3.36%4.03%3.38%
Dividend Yield
0.47%0.97%0.26%1.00%0.94%0.85%
Payout Ratio
27.73%13.14%131.81%44.78%35.95%18.67%
Buyback Yield / Dilution
8.40%4.48%-0.23%0.61%-3.37%-0.07%
Total Shareholder Return
8.88%5.45%0.03%1.61%-2.43%0.78%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.